Triazole ring-containing phenylalanine derivative as well as preparation method and application thereof

A technology of phenylalanine and derivatives is applied in the fields of organic compound synthesis and medical application, and can solve the problems of low curative effect and the like

Active Publication Date: 2018-05-15
SHANDONG UNIV
View PDF2 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although PF-74 has a novel structure, unique mechanism, and clear targets, compared with currently marketed anti-HIV-1 drugs, PF-74 has lower efficacy, and its activity is at the micromolar level.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Triazole ring-containing phenylalanine derivative as well as preparation method and application thereof
  • Triazole ring-containing phenylalanine derivative as well as preparation method and application thereof
  • Triazole ring-containing phenylalanine derivative as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Example 1: Key intermediate (S)-N-(1-(4-methoxyphenyl)(methyl)amino)-1-carbonyl-3-phenyl-2-yl)propynamide (4 ) preparation

[0056] The starting material Boc-L-phenylalanine (1) (8.75mmol, 2.3g) was added to 15mL of anhydrous dichloromethane solution, and then 1H-benzotriazol-1-yl was added to this solution Oxytripyrrolidinyl hexafluorophosphate (10.9 mmol, 5.7 g). Stir under ice bath conditions for 0.5h, then add N,N-diisopropylethylamine (21.87mmol, 3.61mL) and N-methyl-4-aminoanisole (7.29mmol, 1.0g), remove the ice bath , stirred at room temperature for 12h. After the reaction was completed, the solvent was evaporated under reduced pressure, then saturated sodium bicarbonate solution was added to the residue in the bottle, extracted with ethyl acetate; the organic layer was separated, 1N HCl solution was added, extracted with ethyl acetate; the organic layers were combined, saturated with Wash with brine, dry the organic phase with anhydrous sodium sulfate; filte...

Embodiment 2

[0059] Embodiment 2. the synthesis of target product WG1-WG20

[0060] The key intermediate 4 (0.297mmol, 1eq) and the prepared azide (0.357mmol, 1.2eq) were added into a mixed solvent of tetrahydrofuran and water (v / v=1:1, 10mL). Sodium ascorbate (0.0891 mmol, 17.65 mg) and copper sulfate pentahydrate (0.0297 mmol, 7.43 mg) were then added to this solution. The mixed solution was heated to 30-65°C and stirred vigorously for 4-12h. Subsequently, an appropriate amount of water was added to the reaction solution, extracted with ethyl acetate; the organic layer was separated and dried over anhydrous sodium sulfate; filtered and evaporated to dryness under reduced pressure; silica gel column chromatography; The target compounds WG1-WG20 were obtained by recrystallization from methane / n-hexane.

[0061]

[0062] The azide used was zidovudine. The product is a white solid, yield: 50%, melting point 143-145°C.

[0063] 1 H NMR (400MHz, DMSO-d 6 )δ11.37(s,1H),8.73(s,1H),8.35(...

Embodiment 3

[0120] Embodiment 3. In vitro anti-HIV-1 activity test (MT-4 cell) experiment of target compound

[0121] Principle: Luciferase reporter gene assay (HIV-1NL4-3 with nef gene deletion)

[0122] testing method:

[0123] Multicycle Virus Replication Assay in MT-4 Cells

[0124] Inoculated with MT-4 cells (1x 10 5cells / mL) on a 96-well cell culture plate, each well was added with different concentrations of target compounds (WG1-WG20 and PF-74), and then HIV-1NL4-3Nanoluc-sec virus strain (50TCID 50 / well) to infect MT-4 cells. The HIV-1NL4-3Nanoluc-sec used is a responder virus, which is inserted into the secNluc sequence in pNL1.3[secNluc] through the Not I and Xho I restriction endonuclease sites to replace the nuclear spanning DNA in the pNL4-3 plasmid. Nef sequence at nucleotides 8796-8892. Wherein, the Not I site is introduced into the pNL4-3 plasmid by the site-directed mutagenesis technique, and the Xho I site is a unique site existing in the pNL4-3 plasmid. After HI...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Melting pointaaaaaaaaaa
Login to view more

Abstract

The invention relates to a triazole ring-containing phenylalanine derivative as well as a preparation method and application thereof. A compound has a structure shown in formula I. The invention alsorelates to a medicine composition containing the compound with the structure shown in the formula I, and also provides application of the compound and the composition containing one or multiple compounds in preparation of medicines for treating and preventing acquired immune deficiency syndrome. (The formula I is shown in the attached figure.).

Description

technical field [0001] The invention belongs to the technical field of organic compound synthesis and medical application, and specifically relates to a phenylalanine derivative containing a triazole ring and a preparation method and application thereof. Background technique [0002] AIDS (Acquired Immune Deficiency Syndrome, AIDS) is a major infectious disease mainly caused by Human Immunodeficiency Virus Type 1 (Human Immunodeficiency Virus Type 1, HIV-1), which endangers human life and health. Currently, clinically used drugs for the treatment of AIDS are mainly divided into four categories: reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, and fusion inhibitors according to different targets. "Highly Active Antiretroviral Therapy" (Highly Active Antiretroviral Therapy, HAART) prolongs the survival time of patients to a large extent and improves the quality of life of patients, but the problems of drug resistance, drug side effects, latent infec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D405/14C07D249/04C07D405/04A61K31/513A61K31/4192A61P31/18
CPCC07D249/04C07D405/04C07D405/14
Inventor 展鹏武高禅刘新泳李国雄康东伟俞霁孙林
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap